| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coronary vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium nitroprusside 25mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diazoxide 15mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely diazoxide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Substance with endothelin receptor antagonist mechanism of action (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human B-type natriuretic peptide |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Treprostinil sodium |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amyl nitrite (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydralazine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Minoxidil |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prenylamine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclandelate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nimodipine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nicorandil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oxerutins |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naftidrofuryl |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tolazoline (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing diazoxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product acting as vasodilator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nitroprusside-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by nitrite (disorder) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tolazoline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 10mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 3% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole 50mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guanethidine monosulfate and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diazoxide 15mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to coronary vasodilators NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to other vasodilators |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to vasodilators NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole 10 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fenoldopam (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Xanthine |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flosequinan |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Inositol niacinate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Xanthinol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alpha adrenergic receptor antagonist |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dipyridamole |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betahistine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Coronary vasodilators causing adverse effects in therapeutic use, not elsewhere classified |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental diazoxide poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional diazoxide poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication accidentelle par un nitrite |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional nitrite poisoning (event) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ranolazine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aviptadil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nesiritide (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levosimendan (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to vasodilator |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Molsidomine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to coronary vasodilator |
Causative agent (attribute) |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dihydralazine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Trimetazidine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hexobendine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Riociguat (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing treprostinil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Treprostinil 600 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human B-type natriuretic peptide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guanethidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Selexipag (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Treprostinil |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium nitroprusside dihydrate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline anhydrous (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline hydrate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betahistine mesilate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanadrel sulfate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Moxisylyte hydrochloride (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Labetalol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Indoramin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alfuzosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Yohimbine hydrochloride (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atipamezole (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Doxazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Yohimbine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Urapidil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Moxisylyte (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Azapetine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Terazosin hydrochloride (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Terazosin |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]